Q-omics provides the consensus-scored TRBV5-2 profile across patient tissues and cancer cell-line models. TRBV5-2 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, TRBV5-2 RNA expression shows 8,630 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, and THYM as cancer lineages where TRBV5-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.